Acorda Therapeutics Inc EV/EBITDA
Qual é o EV/EBITDA de Acorda Therapeutics Inc?
O EV/EBITDA de Acorda Therapeutics Inc é N/A
Qual é a definição de EV/EBITDA?
EV/EBITDA é o valor da empresa dividido pelo lucro antes de juros, impostos, depreciação e amortização. É uma medida de quão cara é uma ação e é mais frequentemente válida para comparações entre empresas do que da relação entre preço e lucro. Ele mede o preço (na forma de valor da empresa) que um investidor paga em benefício do fluxo de caixa da empresa (na forma de EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA de empresas na Setor Health Care em NASDAQ em comparação com Acorda Therapeutics Inc
O que Acorda Therapeutics Inc faz?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Empresas com ev/ebitda semelhantes a Acorda Therapeutics Inc
- Jia Yao tem EV/EBITDA de N/A
- CLS USA tem EV/EBITDA de N/A
- Overseas Chinese Town (Asia) tem EV/EBITDA de N/A
- Starr Peak Exploration tem EV/EBITDA de N/A
- Good Friend International tem EV/EBITDA de N/A
- DoorDash Inc tem EV/EBITDA de N/A
- Acorda Therapeutics Inc tem EV/EBITDA de N/A
- Inspur International tem EV/EBITDA de N/A
- Setubandhan Infrastructure tem EV/EBITDA de N/A
- Avalon Works tem EV/EBITDA de N/A
- Galileo Mining Ltd tem EV/EBITDA de N/A
- Trine Acquisition tem EV/EBITDA de N/A
- Dreadnought Resour tem EV/EBITDA de N/A